Notice of Intent to use Other than full and open competition for procurement of Over The Counter (OTC) COVID-19 Tests
Award Details
- Contract Award Date: Sep 20, 2023
- Contract Award Number: 75A50223C00034-75A50223C00035-75A50223C00036-75A50223C00037-75A50223C00038-75A50223C00039-75A50223C00040-75A50223C00041-75A50223C00042-75A50223C00043-75A50223C00044-75A50223C00045-75A50223C00046-75A50223C00048
- Task/Delivery Order Number:
- Modification Number:
- Contractor Awarded Unique Entity ID:
General Information
- Contract Opportunity Type: Justification (Updated)
- Updated Published Date: Sep 21, 2023 03:15 pm EDT
- Original Published Date: Sep 01, 2023 11:18 am EDT
- Inactive Policy: Manual
- Updated Inactive Date: Oct 21, 2023
- Original Inactive Date: Oct 01, 2023
- Initiative:
- None
Classification
- Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- NAICS Code:
- 325413 - In-Vitro Diagnostic Substance Manufacturing
- Place of Performance: USA
Description
The Department of Health and Human Services (DHHS), Administration for Strategic Preparedness and Response (ASPR) intends on issuing 13 contracts, on or about 09/15/2023, to domestic manufacturers of Over the Counter (OTC) COVID-19 tests, in accordance with 41 U.S.C. 3304(a)(3)(A) and FAR 6.302-3(a)(2)(i). See attached for additional details, including minimum requirements and delivery locations. All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency. If interested in obtaining a copy of the solicitation, send an email to: ibmscc-submissions@hhs.gov.
Organization: DHHS/ASPR
Contracting Office Address: 400 7th Street, SW, Washington, DC
Contracting Office Zip Code: 20024
Product or Service Code (PSC): 6550 In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets
NAICS Code: 325413 In-Vitro Diagnostic Substance Manufacturing
Place of Performance: Contractor facility
Procedures to be used in awarding the contracts: Direct written solicitations
The above notice is an updated notice to add an additional vendor that was included in the award. The updated notice is applicable to the updated Justification and Approval. Nothing else has changed in the updated Justification and approval.
The Department of Health and Human Services (DHHS), Administration for Strategic Preparedness and Response (ASPR) intends on issuing 14 contracts, on or about 09/15/2023, to domestic manufacturers of Over the Counter (OTC) COVID-19 tests, in accordance with 41 U.S.C. 3304(a)(3)(A) and FAR 6.302-3(a)(2)(i). See attached for additional details, including minimum requirements and delivery locations. All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency. If interested in obtaining a copy of the solicitation, send an email to: ibmscc-submissions@hhs.gov.
The Government intends to make awards to known viable and capable domestic manufacturers that meet all the government requirements, based on market research and responses received to the posted synopses”. Organization: DHHS/ASPR
Contracting Office Address: 400 7th Street, SW, Washington, DC
Contracting Office Zip Code: 20024
Product or Service Code (PSC): 6550 In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets
NAICS Code: 325413 In-Vitro Diagnostic Substance Manufacturing
Place of Performance: Contractor facility
Procedures to be used in awarding the contracts: Direct written solicitations
Attachments/Links
Contact Information
Contracting Office Address
- O’NEILL HOUSE OFFICE BUILDING
- Washington , DC 20515
- USA
Primary Point of Contact
- Mary Masamo
- IBMSCC-Submissions@hhs.gov
Secondary Point of Contact
History
- Oct 21, 2023 11:55 pm EDTJustification (Updated)
- Sep 01, 2023 11:22 am EDTJustification (Updated)
- Sep 01, 2023 11:18 am EDTJustification (Original)